Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China · Delayed Price · Currency is CNY 3.240
-0.040 (-1.22%)
Sep 10, 2026, 12:44 PM CST
SHE:300267 Revenue
Hunan Er-Kang Pharmaceutical had revenue of 320.17M CNY in the quarter ending June 30, 2026, a decrease of -2.49%. This brings the company's revenue in the last twelve months to 1.05B, down -12.39% year-over-year. In the year 2025, Hunan Er-Kang Pharmaceutical had annual revenue of 1.17B with 2.29% growth.
Revenue (ttm)
1.05B
Revenue Growth
-12.39%
P/S Ratio
6.43
Revenue / Employee
827.25K
Employees
1,271
Market Cap
6.77B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.17B | 26.15M | 2.29% |
| Dec 31, 2024 | 1.14B | -643.51M | -36.09% |
| Dec 31, 2023 | 1.78B | -87.42M | -4.67% |
| Jan 1, 2023 | 1.87B | -364.76M | -16.32% |
| Jan 1, 2022 | 2.24B | -146.97M | -6.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.